Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...

Joyce Siette, Western Sydney University A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold ...

Australia's Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer's ...

Adoption of lecanemab, a novel infusion treatment for Alzheimer’s disease (AD), has been disproportionately higher among ...

Certain antihistamines found in common allergy medications and sleep aids are liked to an increased dementia risk. Doctors ...

Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's disease (AD) and other conditions that ...

Research has suggested a link between herpes simplex virus type-1 (HSV-1) and an increased risk of Alzheimer's disease. The ...

Dementia affects millions globally, impacting memory, reasoning, and everyday activities. As the population ages, ...

A care company has been plunged into special measures after it emerged vulnerable people “were not safe” and at risk of harm.

Serena Coleman, CQC deputy director of operations in the south, said in a report released on Friday that Share the Care ...

Investigations have begun after a person was found dead in a Melbourne house fire overnight. A team has gathered to compete in HBF's Run for a Reason in honour of former AFL star Adam Selwood who died ...